Jaclyn Roman

Jaclyn Roman is a Researcher affiliated with Yale School of Medicine’s YNHH Research division. Her work focuses on gynecological cancers, particularly uterine and cervical carcinomas, with an emphasis on immunotherapy, molecular markers, and targeted treatments. Key research areas include hormonal therapies for endometrial cancer, dendritic cell-based vaccines, and the role of Claudin proteins in cancer progression.

Her collaborative studies involve phase I clinical trials for cervical cancer vaccines and gene expression profiling to identify novel diagnostic markers. She has co-authored studies on tumor immune responses and cytotoxic lymphocyte activation in ovarian cancer patients.

Publications span 2004-2006, highlighting interdisciplinary approaches in oncology and immunology. While no explicit awards are listed, her contributions reflect significant engagement in translational cancer research.